AKT1 and colorectal cancer: Further, targeting AKT also considerably inhibited tumor cell growth, migration and invasion similar to the effects of SLPI knockdown, which indicates that AKT is the downstream of SPLI and might be a novel therapeutic target for colorectal cancer treatment with high SPLI expression.